UNBELIEVABLE: Needham person | History Defined

CBRS Stock Watch: Cerebras Soars as Analysts Issue 'Buy' Ratings

Wall Street analysts initiate bullish sentiment on Cerebras stock. Here’s why they believe CBRS shares will rip higher from here as the year unfolds.

Barchart · Jun 9

Omar Kelly: Things we learned in the first week of Dolphins training camp

The first week of training camp is in the books, and the Mike McDaniel era of the Miami Dolphins franchise began about as smoothly as it could have possibly gone.

Tribune News Service · Aug 1, 2022

Needham Says Merus' ASCO Update On Zeno 'Positive'

Needham writes that Merus NV (NASDAQ: MRUS) has enough data to initiate an FDA marketing application filing in mid-2022 after presenting Zenocutuzumab (Zeno) data in NRG1-fusion (NRG1+) Cancer. 

Benzinga · Jun 6, 2022